(ENTA) Enanta Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Enanta Pharmaceuticals | (ENTA) share price targets
Complete technical analysis of Enanta Pharmaceuticals (ENTA) by charts plus indicators, forecast predictions and share price targets for Enanta Pharmaceuticals (ENTA)
Enanta Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Enanta Pharmaceuticals is 282470
| Date | Daily Closing Price | Open | High | Low | Volume |
| 07 Fri Feb 2025 | 4.90 | 5.01 | 5.02 | 4.81 | 1.506 times |
| 06 Thu Feb 2025 | 4.96 | 5.09 | 5.12 | 4.88 | 1.351 times |
| 05 Wed Feb 2025 | 5.07 | 5.12 | 5.28 | 4.98 | 1.181 times |
| 04 Tue Feb 2025 | 5.12 | 5.16 | 5.18 | 4.98 | 1.304 times |
| 03 Mon Feb 2025 | 5.17 | 5.10 | 5.29 | 4.94 | 1.123 times |
| 31 Fri Jan 2025 | 5.11 | 5.09 | 5.31 | 5.04 | 0.628 times |
| 30 Thu Jan 2025 | 5.14 | 5.00 | 5.21 | 4.98 | 0.674 times |
| 29 Wed Jan 2025 | 4.98 | 5.09 | 5.15 | 4.94 | 0.739 times |
| 28 Tue Jan 2025 | 5.12 | 5.23 | 5.35 | 5.10 | 0.883 times |
| 27 Mon Jan 2025 | 5.30 | 5.50 | 5.76 | 5.26 | 0.994 times |
Share price targets for Enanta Pharmaceuticals (ENTA)
| Target Type | Value |
| Downside Target | 4.71 |
| Downside Target | 4.81 |
| Upside Target | 4.94 |
| Upside Target | 5.29 |
| Upside Target | 5.72 |
| Upside Target | 5.76 |
| Upside Target | 6.10 |
| Upside Target | 8.00 |
| Upside Target | 9.46 |
| Upside Target | 9.98 |
| Upside Target | 11.83 |
| Upside Target | 13.37 |
Intraday share price targets for Enanta Pharmaceuticals (ENTA)
| Target Type | Value |
| Downside Intraday Target | 4.71 |
| Downside Intraday Target | 4.52 |
| Upside Intraday Target | 5.19 |
| Upside Intraday Target | 5.48 |
| Upside Intraday Target | 5 |
Weekly technical analysis of Enanta Pharmaceuticals (ENTA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 07 Fri Feb 2025 | 4.90 | 5.10 | 5.29 | 4.81 | 1.65 times |
| 31 Fri Jan 2025 | 5.11 | 5.50 | 5.76 | 4.94 | 0.705 times |
| 24 Fri Jan 2025 | 5.53 | 5.30 | 5.72 | 4.96 | 2.262 times |
| 17 Fri Jan 2025 | 5.25 | 4.87 | 5.31 | 4.83 | 0.195 times |
| 17 Fri Jan 2025 | 5.25 | 4.96 | 5.31 | 4.71 | 1.972 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Enanta Pharmaceuticals (ENTA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 07 Fri Feb 2025 | 4.90 | 5.10 | 5.29 | 4.81 | 0.153 times |
| 31 Fri Jan 2025 | 5.11 | 5.80 | 6.10 | 4.71 | 1.085 times |
| 31 Tue Dec 2024 | 5.75 | 8.12 | 9.46 | 5.30 | 2.843 times |
| 26 Tue Nov 2024 | 8.56 | 11.32 | 11.83 | 8.00 | 1.049 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Enanta Pharmaceuticals (ENTA)
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Enanta Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Enanta Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Enanta Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Enanta Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Enanta Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.07 and Enanta Pharmaceuticals (ENTA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Enanta Pharmaceuticals (ENTA) stock. Volume based technical analysis of Enanta Pharmaceuticals (ENTA) stock is negative.
Enanta Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Enanta Pharmaceuticals ( (ENTA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Enanta Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Enanta Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Enanta Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Enanta Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Enanta Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.07 and Enanta Pharmaceuticals (ENTA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Enanta Pharmaceuticals (ENTA) stock. Volume based technical analysis of Enanta Pharmaceuticals (ENTA) stock is negative.
Enanta Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.